Effect of Four Combination Therapy of Danazol, Erythropoietin, Thalidomide and Alfacalcitol in the Treatment of Myelodysplastic Syndrome

SHANGGUAN Xiaohui; HUANG Jianqing

doi:10.14033/j.cnki.cfmr.2022.34.010

Home>Articles>Effect of Four Combination Therapy of Danazol, Erythropoietin, Thalidomide and Alfacalcitol in the Treatment of Myelodysplastic Syndrome

DOI: 10.14033/j.cnki.cfmr.2022.34.010

Effect of Four Combination Therapy of Danazol, Erythropoietin, Thalidomide and Alfacalcitol in the Treatment of Myelodysplastic Syndrome

SHANGGUAN Xiaohui

HUANG Jianqing

Machine-generated Keywords：

Publication Date：2022-12-05

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 41-45 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2022,20(34)